Accuryn Medical

Accuryn Medical is a private, commercial-stage medical device and digital health company focused on preventing Acute Kidney Injury (AKI) in critical care settings. Its flagship Accuryn® Monitoring System integrates smart sensor technology into a Foley catheter to provide continuous, automated monitoring of urine output, intra-abdominal pressure, and core body temperature, with an AI platform designed to visualize trends and predict AKI risk. The company targets a significant unmet need, as AKI affects hundreds of thousands of patients annually, often as a complication of sepsis or intra-abdominal hypertension. By providing real-time data, Accuryn aims to shift care from reactive to predictive, enabling earlier interventions to improve patient outcomes.

Smart Foley catheter system with integrated sensors for continuous monitoring of urine output, intra-abdominal pressure, and core body temperature, connected to an AI-powered software platform for data visualization and predictive analytics for Acute Kidney Injury (AKI).

Direct competition may come from other startups developing smart catheters or non-invasive monitoring systems for ICU metrics. Indirect competition includes traditional manual monitoring methods and standalone devices for measuring intra-abdominal pressure. Large players like Baxter, BD, or ICU-focused companies could become competitors through internal development or acquisition.